KLINISK-Klinisk forskning
Thalidomide versus Velcade in melphalan refractory multiple myeloma
Standard treatment of patients under the age of 65 with multiple myeloma is high dose melphalan followed by infusion of autologous blood stem cells (ASCT). Standard treatment of patients over the age of 65 is low dose melphalan and prednisolon. Most patie nts respond to this treatment, but patien...